+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Growth Hormone Secretory Patterns in Young, Middle-Aged and Old Female Rats

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          Pulsatile growth hormone (GH) secretion was compared in young (5 months), middle-aged (11 months) and old (25–29 months) female Sprague-Dawley rats under nonanesthetized, free-moving conditions. Mean plasma GH levels were 99.1 ± 9.3 ng/ml in young rats, 56.3 ± 5.8 ng/ml in middle-aged rats and 49.7 ± 4.9 ng/ml in old rats (p < 0.01 for young vs. middle-aged and old rats). In young females, 10 out of 17 rats had GH pulses with peak levels greater than 200 ng/ml, in 6 middle-aged females all GH peaks were below 200 ng/ml, and in old females 13 out of 17 rats showed GH peaks of less than 100 ng/ml. The average peak (amplitude) of GH pulses in the old rats (69.3 ± 8.3 ng/ml) was lower than in the young rats (130.4 ± 17.5 ng/ml, p < 0.01) and somewhat lower than in the middle-aged rats (87.0 ± 8.9 ng/ml). There was no change in intervals between GH pulses. Pituitary GH content in middle-aged and old females (1,189 ± 60 and 1,100 ± 89 µg, respectively) was significantly lower (p < 0.05 and p < 0.01, respectively) than in young female rats (1,464 ± 76 µg). Somatostatin content in the median eminence of old rats (22.4 ± 1.9 ng) was significantly lower than in young rats (28.5 ± 1.6 ng, p < 0.05). It is concluded that GH secretion is reduced in aging female rats, but unlike in aging male rats the decrease is seen at an earlier age. This may account for the relatively early body growth stasis observed in female but not in male rats. Among the possible causes for the decline in GH secretion with aging in these rats are an increase in somatostatin release and a decrease in GHRH release, associated with a reduction in hypothalamic catecholamine activity.

          Related collections

          Author and article information

          S. Karger AG
          02 April 2008
          : 46
          : 2
          : 137-142
          Department of Physiology, Neuroendocrine Research Laboratory, Michigan State University, East Lansing, Mich., USA
          124810 Neuroendocrinology 1987;46:137–142
          © 1987 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 6
          Original Paper


          Comment on this article